REDWOOD CITY, Calif., May 16, 2023 Coherus BioSciences, Inc. today announced the pricing of its underwritten public offering of 11,764,706 shares of its common stock at a price to the public of. | May 16, 2023
Coherus Announces Proposed Public Offering of Common Stock streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
– UDENYCA® autoinjector approved and ready for May 2023 launch –– CIMERLI® product-specific Q-code now facilitating electronic reimbursement following April 1 activation. | May 8, 2023
- Final overall survival analysis of the JUPITER-02 trial shows first-line treatment with toripalimab plus chemotherapy significantly prolongs survival in patients with advanced NPC - SHANGHAI, China
Coherus (CHRS) and Junshi Report Positive Final Overall Survival Results of JUPITER-02 streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.